APLM today
$17.71+$0.21 (+1.20%)close Nov 13, 2026Trend
DailyDowntrend (starting)
4 hourLeaning Bullish
1 hourBearish
15 minLeaning Bearish
5 minConsolidating
Daily trend turns up above $28.29
Key levels
Resistance$21.88
Resistance$19.50
Support$16.90
Support$14.30
Latest news & SEC filings
EarningsApollomics Posts Results for the First Six Months of 2026
EarningsApollomics Narrows First-Half Loss to $4.06 Per Share
NewsApollomics cuts jobs and ends lung cancer trial amid cash shortage
All APLM news →About Apollomics
Apollomics is a clinical-stage biopharmaceutical company focused on discovering and developing oncology therapies. Its lead product candidate is vebreltinib, and it also has programs such as uproleselan. The company operates in the United States and China, and it works with collaborators and licensing partners to develop and commercialize its drug candidates in various territories.
Based on the company's 20-F filed Apr 24, 2026.
Nasdaq · Healthcare
Apollomics Inc. (APLM)
What Is the Price Target for APLM?
SEPT Low Target
$0.00
SEPT Mid Target
$0.00
SEPT High Target
$0.00
Analyst Consensus
$0.00
Is APLM a Buy or Sell Right Now?
AI-Powered Trading Signals
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy for APLM.
Start Free Trial →Is APLM Overvalued or Undervalued?
Valuation Verdict
N/A
Methods Used
N/A
Fair Value
$N/A
0
Moat Score
NONE
1/9
Piotroski Score
N/A
Altman Z-Score
What Is Smart Money Doing with APLM?
Insider Signal
NEUTRAL
0 buys / 0 sells (90d)
Congress Signal
NEUTRAL
0 buys / 0 sells (90d)
Institutional
N/A
Short Squeeze Risk
LOW
Signal: NEUTRAL
Recent Insider Activity
| Name | Title | Type | Shares | Value | Date |
|---|---|---|---|---|---|
| Chen Yi-Kuei | director officer | Buy | 5,000 | - | Sep 15, 2026 |
| LIN PETER KUAN-HOW | officer | Buy | 10,000 | - | Sep 15, 2026 |
| LIN PETER KUAN-HOW | officer | Sale | 3,416 | $82K | Sep 15, 2026 |
| Yen Hung Hsien | director | Buy | 500 | - | Sep 15, 2026 |
| Huang Ya-Chi | director | Buy | 500 | - | May 17, 2026 |
Track Smart Money Across 4,000+ Stocks
Insider trades, congress trades, institutional flows, and short interest — updated daily with real-time alerts.
See All Smart Money Signals →APLM Growth Story
Revenue YoY
N/A%
3yr Revenue CAGR
N/A%
EPS Growth YoY
77.24%
FCF Growth YoY
33.4%
Revenue Trend
UNKNOWN
Dark Pool Trades for APLM
PREVIEWSEPT Investing tracks real-time dark pool institutional trades for APLM, including block trade sizes, dollar values, and buy/sell side classification. Dark pool trades reveal where institutional investors are positioning before moves become visible on public exchanges.
| Time | Price | Size | Value | Side |
|---|---|---|---|---|
| 19:19:26 | $17.68 | 1,000 | $$18K | BUY |
| 19:03:36 | $26.13 | 1,045 | $$27K | BUY |
2 dark pool trades shown · $$45K preview volume
Real-time institutional flow, block trades, and net positioning
Full AI Research Report
SEPT's Trading AI has generated a free, downloadable PDF research report for Apollomics Inc. (APLM) covering valuation analysis, financial health assessment, growth projections, smart money tracking, earnings and key price levels. For research only, not investment advice.
Report includes: PDF download, detailed valuation models (DCF, P/E, EV/EBITDA), institutional flow analysis, congress and insider trade tracking, FinBERT news sentiment (1 articles analyzed), and SEC filing intelligence...
AI-Powered Trading Signals.
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy. SEPT tells you when to buy, when to sell, and grades every stock so you never trade blind.
Try SEPT Free for 7 Days →APLM — frequently asked questions
What is APLM stock price today?
Apollomics Inc. (APLM) is at $17.71, up 1.20% (+$0.21) at the Nov 13, 2026 close.
Why is APLM stock moving today?
Latest APLM news — Nov 10, 2026: Apollomics Posts Results for the First Six Months of 2026 · Nov 9, 2026: Apollomics Narrows First-Half Loss to $4.06 Per Share
Did APLM beat earnings?
APLM last reported on Apr 27, 2026: EPS $3.80.
Does APLM pay a dividend?
APLM does not currently pay a dividend.
How much debt does APLM have?
Apollomics Inc. reported $0M of debt and $10M of cash (Dec 31, 2024).
What are APLM support and resistance levels?
Support: $16.90, $14.30, $12.58. Resistance: $19.50, $21.88, $24.96.
What are insiders doing with APLM?
Insider activity: NEUTRAL, 0 buys and 0 sells in the last 90 days.
What is the latest news on APLM?
Nov 10, 2026: Apollomics Posts Results for the First Six Months of 2026 · Nov 9, 2026: Apollomics Narrows First-Half Loss to $4.06 Per Share · Nov 8, 2026: Apollomics cuts jobs and ends lung cancer trial amid cash shortage